skip to Main Content
Cover of investment in HIV research profoundly benefits the COVID-19 Response

Investment in HIV Research Profoundly Benefits the COVID-19 Response

December 2, 2020 – This policy brief discusses how investment in HIV research has profoundly benefitted the COVID-19 response, and advocates that continued financial support for HIV science can both ensure progress on COVID-19 and avoid losing ground—and lives—in the fight to end the HIV epidemic.

 

Back To Top